. 2019 Oct 12;157(5):1322–1345. doi: 10.1016/j.chest.2019.09.025

Table 11.

Time to Finish Diagnosis and Staging and Time to Treatment Stratified According to Mediastinal Sampling Strategy

	Mediastinal Sampling First: Guideline Consistent	Mediastinal Sampling Second or Later: Guideline Inconsistent	Mediastinal Sampling Never Done
Entire cohort
Median No. of days from first to last invasive test (median, IQR)	0 (0, 5)^a^,^b	34 (21, 52)^a^,^b	0 (0, 0)^a^,^b
Median No. of days from first invasive test to first treatment (median, IQR)	18 (0, 35)^a^,^b	41 (26, 63)^a^,^b	27 (15, 44)^a^,^b
Propensity-matched cohorts
Median No. of days from first to last invasive test (median, IQR)	0 (0, 7)^a	34 (21, 52)^a	…
Median No. of days from first invasive test to first treatment (median, IQR)	18 (0, 35)^a	42 (27, 64)^a	…

See Table 10 legend for expansion of abbreviation.

P < .001, nonparametric Wilcoxon rank sum test comparing mediastinal sampling first vs second or later.

P < .001, nonparametric Kruskal-Wallis test for all three groups.